Basics Travere Therapeutics, Inc. IPO Date: August 15, 2003 Sector: Healthcare Industry: Biotech Market Cap: $1.45B Activated in VL: True Average Daily Range Avg Daily Range: $0.46 | 2.55% Avg Daily Range (30 D): $0.33 | 2.13% Avg Daily Range (90 D): $0.48 | 2.86% Institutional Daily Volume Avg Daily Volume: .92M Avg Daily Volume (30 D): 1.09M Avg Daily Volume (90 D): 1.3M Trade Size Avg Trade Size (Sh.): 84 Avg Trade Size (Sh.) (30 D): 64 Avg Trade Size (Sh.) (90 D): 68 Institutional Trades Total Inst.Trades: 3,177 Avg Inst. Trade: $2.02M Avg Inst. Trade (30 D): $2.59M Avg Inst. Trade (90 D): $2.64M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.86M Avg Closing Trade (30 D): $3.66M Avg Closing Trade (90 D): $4.33M Avg Closing Volume: 170.21K     News Mar 17, 2025 @ 11:01 AM Travere Therapeutics Submits sNDA to FDA for Appro... Source: N/A Feb 12, 2025 @ 10:30 PM Travere Therapeutics Reports Inducement Grants Und... Source: N/A Jan 6, 2025 @ 9:30 PM Travere Therapeutics to Present at the 43rd Annual... Source: N/A Nov 13, 2024 @ 10:00 PM Travere Therapeutics Reports Inducement Grants Und... Source: N/A Nov 8, 2024 @ 2:05 AM Travere Therapeutics Announces Pricing of Public O... Source: Globe Newswire Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.47 $-.7 $-.91 Diluted EPS $-.47 $-.7 $-.91 Revenue $ 81.73M $ 62.9M $ 54.12M Gross Profit $ 77.05M $ 61.27M $ 52.06M Net Income / Loss $ -41.23M $ -54.81M $ -70.41M Operating Income / Loss $ -42.67M $ -56.15M $ -67.7M Cost of Revenue $ 4.68M $ 1.63M $ 2.06M Net Cash Flow $ 3.36M $ 4.12M $ -10.96M PE Ratio     Splits Nov 08, 2011:   1:9